OT: A choice between [Design Issues]

posted by BEQool  – 2024-10-23 15:17 (241 d 03:50 ago) – Posting: # 24248
Views: 6,046

Hello Helmut,

of course I unfortunately dont know the answers to your questions but

❝ [...] or PEs by model 3 (i.e., the conventional one with any group terms)? What would an assessor conclude from any of those? Even if they would calculate the CI of groups separately, likely they would overlap. So what?


Isnt it so that if we detect Group*Treatment interaction, the CIs of groups seperately very likely wouldnt overlap? That is why we detect an interaction?

BEQool

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
67 visitors (0 registered, 67 guests [including 14 identified bots]).
Forum time: 19:08 CEST (Europe/Vienna)

Medical researches can be divided into two sorts:
those who think that meta is better and those
who believe that pooling is fooling.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5